Liebl, Andreas http://orcid.org/0000-0002-6911-4298
Mohan, Viswanathan
Yang, Wenying
Strojek, Krzysztof
Linjawi, Sultan
Funding for this research was provided by:
Novo Nordisk
Article History
First Online: 21 February 2018
Compliance with Ethical Standards
:
: AL has received funding for membership on Novo Nordisk and Eli Lilly advisory boards and/or consulting services and for lectures from Novo Nordisk, Eli Lilly, Sanofi, Boehringer-Ingelheim, AstraZeneca, Roche, and MSD. VM has received research grants and honoraria from Novo Nordisk, Sanofi, MSD, Johnson & Johnson, and Eli Lilly and lecture fees from Novo Nordisk. WY has attended advisory boards and been a speaker for Novo Nordisk. KS has received honoraria for speaking engagements from Eli Lilly, Novo Nordisk, Sanofi-Aventis, Servier, Boehringer-Ingelheim, and Polfa-Tarchomin and has participated in clinical trials for AstraZeneca, Pfizer, and Amgen. SL has received funding for advisory activities from Novo Nordisk and for speaker activities from Novo Nordisk, Novartis Pharma AG, Roche Pharmaceuticals, and AstraZeneca Pharmaceuticals LP.